Last Updated : March 13, 2025
Details
FilesGeneric Name:
guanfacine hydrochloride extended-release
Project Status:
Pending
Therapeutic Area:
Attention Deficit Hyperactivity Disorder (ADHD)
Manufacturer:
N/A
Call for patient/clinician input open:
Brand Name:
N/A
Project Line:
Reimbursement Review
Project Number:
SX0755-000
Call for patient/clinician input closed:
Biosimilar:
No
Submission Type:
Non-sponsored Submission
Fee Schedule:
Pending
Indications:
Attention Deficit Hyperactivity Disorder (ADHD)
Files
Last Updated : March 13, 2025